Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-26 @ 1:43 AM
Study NCT ID:
NCT03496233
Status:
COMPLETED
Last Update Posted:
2023-02-22
First Post:
2018-02-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in G1b Treatment-Naïve, HCV-Infected Patients
Sponsor:
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-20
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-16
First Submit QC Date:
None
Study First Post Date:
2018-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-21
Last Update Post Date:
2023-02-22
Last Update Post Date Type:
ACTUAL